G4005-96E
Clone Type
PolyclonalHost
RabbitSource
HumanIsotype
IgGGrade
Affinity PurifiedApplications
WBCrossreactivity
Hu Mo RtAccession #
NP_000822Shipping Temp
Blue IceStorage Temp
-20°CRabbit Anti-Grik3 (EAA5, Excitatory amino acid receptor 5, GLR7, GluR7, GLUR7, GluR-7, GluR7a, Glutamate receptor, ionotropic kainate 3 precursor, Glutamate receptor 7)
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes (1). Grik3, also known as glutamate receptor 7, belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels (2,3). Grik3 is highly homologous to the related ionotrophic glutamate receptors Grik2 and Grik1. Grik3 has recently been shown to be an essential subunit of presynaptic kainate autoreceptors at hippocampal mossy fiber synapses as grik3-null mice show significantly reduced short- and long-term synaptic potentiation (4). Other reports have suggested that different polymorphisms in the Grik3 protein may be associated with neurological defects such as recurrent major depressive disorder and schizophrenia (5,6). This Grik3 antibody does not cross-react with Grik2.
Applications
Suitable for use in Western Blot. Other applications not tested.
Recommended Dilutions
Western Blot: 1-2ug/ml Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Immunogen
Synthetic peptide corresponding to 13aa near the amino terminus of the human Grik3.
Form
Supplied as a liquid in PBS, 0.02% sodium azide.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes human Grik3. Species Crossreactivity: mouse and rat.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
References
1. Tanaka K. Cell Tissue Res. 2006; 326:457-82. 3. Puranam RS, Eubanks JH, Heinemann SF, et al. Somat. Cell Mol. Genet. 1993; 19:581-8. 4. Pinheiro PS, Perrais D, Coussen F, et al. Proc. Natl. Acad. Sci. USA 2007; 104:12181-6. 5. Schiffer HH and Heinemann SF. Am. J. Genet. B. Neuropsychiatr. Genet. 2007; 144:20-6. 6. Begni S, Popli M, Moraschi S, et al. Mol. Psych. 2002; 7:416-8.USBio References
No references available